Related Experiment Video
Updated: Mar 18, 2026
10:05
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
9.0K
Cardiohepatic Interactions: Implications for Management in Advanced Heart Failure
Akshay Pendyal1, Jill M Gelow1
1Knight Cardiovascular Institute, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, UHN 62, Portland, OR 97239, USA.
Heart Failure Clinics
|July 3, 2016
Summary
Heart failure can cause liver disease, ranging from mild injury to severe cardiac cirrhosis. Understanding this link is crucial for managing advanced heart failure patients and improving their prognosis.
Area of Science:
- Cardiology
- Hepatology
- Internal Medicine
Background:
- Heart failure frequently leads to liver disease.
- Liver conditions in heart failure span from reversible injury to advanced fibrosis and cirrhosis.
- These liver complications significantly impact patient outcomes and treatment strategies.
Purpose of the Study:
- To review the current understanding of liver disease in heart failure.
- To provide a framework for managing liver disease in advanced heart failure.
- To highlight the implications of liver disease on prognosis and treatment.
Main Methods:
- Literature review of existing studies on heart failure and liver disease.
- Synthesis of current knowledge on the pathophysiology and clinical manifestations.
- Development of a practical approach for clinicians.
Main Results:
- Liver disease is a common and serious complication of heart failure.
- Hepatic fibrosis and cirrhosis in heart failure affect prognosis, medication, and transplant eligibility.
- A structured approach is needed for liver disease management in this population.
Conclusions:
- Liver disease is an integral consideration in advanced heart failure management.
- Early recognition and management of liver dysfunction can improve patient outcomes.
- Further research is needed to optimize therapeutic strategies for cardiac hepatopathy.
Keywords:
Advanced heart failureChronic heart failureCirrhosisHeart transplantationHepatic fibrosisHepatitis CLiver diseaseMechanical circulatory supportMore Related Videos
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
324
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
324
01:30Heart Failure V: Medical Management
478
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
478
01:22Heart Failure VI: Adjunct Therapies
511
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
511
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
01:29Cardiomyopathy V: Interprofessional Care
591
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
591
01:22Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K